{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:33:45Z","timestamp":1786980825554,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Berta Kamprad Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the advanced stages, malignant melanoma (MM) has a very poor prognosis. Due to tremendous efforts in cancer research over the last 10\u00a0years, and the introduction of novel therapies such as targeted therapies and immunomodulators, the rather dark horizon of the median survival has dramatically changed from under 1\u00a0year to several years. With the advent of proteomics, deep-mining studies can reach low-abundant expression levels. The complexity of the proteome, however, still surpasses the dynamic range capabilities of current analytical techniques. Consequently, many predicted protein products with potential biological functions have not yet been verified in experimental proteomic data. This category of \u2018missing proteins\u2019 (MP) is comprised of all proteins that have been predicted but are currently unverified. As part of the initiative launched in 2016 in the USA, the European Cancer Moonshot Center has performed numerous deep proteomics analyses on samples from MM patients. In this study, nine MPs were clearly identified by mass spectrometry in MM metastases. Some MPs significantly correlated with proteins that possess identical PFAM structural domains; and other MPs were significantly associated with cancer-related proteins. This is the first study to our knowledge, where unknown and novel proteins have been annotated in metastatic melanoma tumour tissue.<\/jats:p>","DOI":"10.1007\/s10565-019-09494-4","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T06:14:34Z","timestamp":1570688074000},"page":"261-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Novel functional proteins coded by the human genome discovered in metastases of melanoma patients"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0278-8802","authenticated-orcid":false,"given":"Aniel","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kuras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy Rodriguez","family":"Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Pla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Pawlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Marcell","family":"Szasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeovanis","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio C. S.","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasset","family":"Perez-Riverol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatan","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Appelqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasso","family":"Miliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Baldetorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ingvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Ekedahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Horvatovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Welinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Wieslander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jeong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto B.","family":"Domont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Rezeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaro Hiram","family":"Betancourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Marko-Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"issue":"4","key":"9494_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1101\/gr.103697.109","volume":"20","author":"MF Berger","year":"2010","unstructured":"Berger MF, Levin JZ, Vijayendran K, Sivachenko A, Adiconis X, Maguire J, et al. Integrative analysis of the melanoma transcriptome. Genome Res. 2010;20(4):413\u201327. \n                  https:\/\/doi.org\/10.1101\/gr.103697.109\n                  \n                .","journal-title":"Genome Res"},{"issue":"1","key":"9494_CR2","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.1038\/s41598-019-41625-z","volume":"9","author":"LH Betancourt","year":"2019","unstructured":"Betancourt LH, Paw\u0142owski K, Jonatan E, Marcell Szasz A, Mitra S, Pla I, et al. Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data. Sci Rep. 2019;9(1):5154. \n                  https:\/\/doi.org\/10.1038\/s41598-019-41625-z\n                  \n                .","journal-title":"Sci Rep"},{"issue":"11","key":"9494_CR3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41591-018-0198-0","volume":"24","author":"CU Blank","year":"2018","unstructured":"Blank CU, Rozeman EA, Fanchi LF, Sikorska K, van de Wiel B, Kvistborg P, et al. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma. Nat Med. 2018;24(11):1655\u201361. \n                  https:\/\/doi.org\/10.1038\/s41591-018-0198-0\n                  \n                .","journal-title":"Nat Med"},{"key":"9494_CR4","unstructured":"Bosman, FT, F Carneiro, RH Hruban, and ND Theise. 2010. WHO classification of tumours of the digestive system.\n\n                  https:\/\/www.cabdirect.org\/cabdirect\/abstract\/20113051318\n                  \n                ."},{"key":"9494_CR5","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Network, Rehan A, Kadir C. Akdemir, B. Arman Aksoy, Monique Albert, Adrian Ally, Samirkumar B. Amin, Harindra Arachchi, et al. 2015. \u201cGenomic classification of cutaneous melanoma.\u201d Cell 161 (7): 1681\u20131696. \n                  https:\/\/doi.org\/10.1016\/j.cell.2015.05.044\n                  \n                .","DOI":"10.1016\/j.cell.2015.05.044"},{"issue":"1","key":"9494_CR6","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/cddiscovery.2017.71","volume":"3","author":"M Cassandri","year":"2017","unstructured":"Cassandri M, Smirnov A, Novelli F, Pitolli C, Agostini M, Malewicz M, et al. Zinc-finger proteins in health and disease. Cell Death Dis. 2017;3(1):17071. \n                  https:\/\/doi.org\/10.1038\/cddiscovery.2017.71\n                  \n                .","journal-title":"Cell Death Dis"},{"issue":"1","key":"9494_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/wsbm.1198","volume":"5","author":"R Chen","year":"2013","unstructured":"Chen R, Snyder M. Promise of personalized omics to precision medicine. Wiley Interdiscip Rev Syst Biol Med. 2013;5(1):73\u201382. \n                  https:\/\/doi.org\/10.1002\/wsbm.1198\n                  \n                .","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"9","key":"9494_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793\u20135. \n                  https:\/\/doi.org\/10.1056\/NEJMp1500523\n                  \n                .","journal-title":"N Engl J Med"},{"key":"9494_CR9","doi-asserted-by":"publisher","unstructured":"Dimitriou F, Krattinger R, Ramelyte E, Barysch MJ, Micaletto S, Dummer R, et al. The world of melanoma: epidemiologic, genetic, and anatomic differences of melanoma across the globe. Curr Oncol Rep. 2018;20. \n                  https:\/\/doi.org\/10.1007\/s11912-018-0732-8\n                  \n                .","DOI":"10.1007\/s11912-018-0732-8"},{"key":"9494_CR10","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1093\/nar\/gkz376","volume":"47","author":"O Elsesser","year":"2019","unstructured":"Elsesser O, Fr\u00f6b F, K\u00fcspert M, Tamm ER, Fujii T, Fukunaga R, et al. Chromatin remodeler Ep400 ensures oligodendrocyte survival and is required for myelination in the vertebrate central nervous system. Nucleic Acids Res. 2019;47:6208\u201324. \n                  https:\/\/doi.org\/10.1093\/nar\/gkz376\n                  \n                .","journal-title":"Nucleic Acids Res"},{"issue":"7688","key":"9494_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature25187","volume":"553","author":"Z Eroglu","year":"2018","unstructured":"Eroglu Z, Zaretsky JM, Hu-Lieskovan S, Kim DW, Algazi A, Johnson DB, et al. High response rate to PD-1 blockade in desmoplastic melanomas. Nature. 2018;553(7688):347\u201350. \n                  https:\/\/doi.org\/10.1038\/nature25187\n                  \n                .","journal-title":"Nature"},{"issue":"1","key":"9494_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/BST20140290","volume":"43","author":"M Gallon","year":"2015","unstructured":"Gallon M, Cullen PJ. Retromer and sorting nexins in endosomal sorting. Biochem Soc Trans. 2015;43(1):33\u201347. \n                  https:\/\/doi.org\/10.1042\/BST20140290\n                  \n                .","journal-title":"Biochem Soc Trans"},{"issue":"D1","key":"9494_CR13","doi-asserted-by":"publisher","first-page":"D764","DOI":"10.1093\/nar\/gku1178","volume":"43","author":"P Gaudet","year":"2015","unstructured":"Gaudet P, Michel P-A, Zahn-Zabal M, Cusin I, Duek PD, Evalet O, et al. The NeXtProt knowledgebase on human proteins: current status. Nucleic Acids Res. 2015;43(D1):D764\u201370. \n                  https:\/\/doi.org\/10.1093\/nar\/gku1178\n                  \n                .","journal-title":"Nucleic Acids Res"},{"key":"9494_CR14","doi-asserted-by":"publisher","unstructured":"Gil J, Betancourt LH, Pla I, Sanchez A, Appelqvist R, Miliotis T, et al. Clinical protein science in translational medicine targeting malignant melanoma. Cell Biol Toxicol. 2019. \n                  https:\/\/doi.org\/10.1007\/s10565-019-09468-6\n                  \n                .","DOI":"10.1007\/s10565-019-09468-6"},{"issue":"1","key":"9494_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009a;37(1):1\u201313. \n                  https:\/\/doi.org\/10.1093\/nar\/gkn923\n                  \n                .","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"9494_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009b;4(1):44\u201357. \n                  https:\/\/doi.org\/10.1038\/nprot.2008.211\n                  \n                .","journal-title":"Nat Protoc"},{"issue":"suppl","key":"9494_CR17","doi-asserted-by":"publisher","first-page":"W38","DOI":"10.1093\/nar\/gkr441","volume":"39","author":"L Jaroszewski","year":"2011","unstructured":"Jaroszewski L, Li Z, Cai X-h, Weber C, Godzik A. FFAS server: novel features and applications. Nucleic Acids Res. 2011;39(suppl):W38\u201344. \n                  https:\/\/doi.org\/10.1093\/nar\/gkr441\n                  \n                .","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"9494_CR18","doi-asserted-by":"publisher","first-page":"acs.jproteome.8","DOI":"10.1021\/acs.jproteome.8b00792","volume":"18","author":"M Kuras","year":"2018","unstructured":"Kuras M, Betancourt LH, Rezeli M, Rodriguez J, Szasz M, Zhou Q, et al. Assessing automated sample preparation technologies for high-throughput proteomics of frozen well characterized tissues from swedish biobanks. J Proteome Res. 2018;18(1):acs.jproteome.8b00792. \n                  https:\/\/doi.org\/10.1021\/acs.jproteome.8b00792\n                  \n                .","journal-title":"J Proteome Res"},{"issue":"20","key":"9494_CR19","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1002\/1873-3468.12433","volume":"590","author":"JT Kwon","year":"2016","unstructured":"Kwon JT, Jin S, Choi H, Kim JJ, Jeong J, Kim JJ, et al. TEX13 is a novel male germ cell-specific nuclear protein potentially involved in transcriptional repression. FEBS Lett. 2016;590(20):3526\u201337. \n                  https:\/\/doi.org\/10.1002\/1873-3468.12433\n                  \n                .","journal-title":"FEBS Lett"},{"issue":"1","key":"9494_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1600-065X.2012.01116.x","volume":"247","author":"S-U Lee","year":"2012","unstructured":"Lee S-U, Maeda T. POK\/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function. Immunol Rev. 2012;247(1):107\u201319. \n                  https:\/\/doi.org\/10.1111\/j.1600-065X.2012.01116.x\n                  \n                .","journal-title":"Immunol Rev"},{"issue":"7","key":"9494_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5483\/BMBRep.2014.47.7.075","volume":"47","author":"J-H Lim","year":"2014","unstructured":"Lim J-H. Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells. BMB Rep. 2014a;47(7):405\u201310 \n                  http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24856827\n                  \n                .","journal-title":"BMB Rep"},{"issue":"7","key":"9494_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5483\/BMBREP.2014.47.7.075","volume":"47","author":"J-H Lim","year":"2014","unstructured":"Lim J-H. Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells. BMB Rep. 2014b;47(7):405\u201310. \n                  https:\/\/doi.org\/10.5483\/BMBREP.2014.47.7.075\n                  \n                .","journal-title":"BMB Rep"},{"issue":"1","key":"9494_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-018-9446-9","volume":"35","author":"A Marcell Szasz","year":"2019","unstructured":"Marcell Szasz A, Malm J, Rezeli M, Sugihara Y, Betancourt LH, Rivas D, et al. Challenging the heterogeneity of disease presentation in malignant melanoma\u2014impact on patient treatment. Cell Biol Toxicol. 2019;35(1):1\u201314. \n                  https:\/\/doi.org\/10.1007\/s10565-018-9446-9\n                  \n                .","journal-title":"Cell Biol Toxicol"},{"issue":"D1","key":"9494_CR24","doi-asserted-by":"publisher","first-page":"D200","DOI":"10.1093\/nar\/gkw1129","volume":"45","author":"A Marchler-Bauer","year":"2017","unstructured":"Marchler-Bauer A, Yu B, Han L, He J, Lanczycki CJ, Lu S, et al. CDD\/SPARCLE: functional classification of proteins via subfamily domain architectures. Nucleic Acids Res. 2017;45(D1):D200\u20133. \n                  https:\/\/doi.org\/10.1093\/nar\/gkw1129\n                  \n                .","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"9494_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41467-017-00449-z","volume":"8","author":"RM Mbofung","year":"2017","unstructured":"Mbofung RM, McKenzie JA, Malu S, Zhang M, Peng W, Liu C, et al. HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes. Nat Commun. 2017;8(1):451. \n                  https:\/\/doi.org\/10.1038\/s41467-017-00449-z\n                  \n                .","journal-title":"Nat Commun"},{"issue":"12","key":"9494_CR26","doi-asserted-by":"publisher","first-page":"e0210234","DOI":"10.1371\/journal.pone.0210234","volume":"13","author":"JR Murillo","year":"2018","unstructured":"Murillo JR, Kuras M, Rezeli M, Miliotis T, Betancourt L, Marko-Varga G. Correction: automated phosphopeptide enrichment from minute quantities of frozen malignant melanoma tissue. PLoS One. 2018;13(12):e0210234. \n                  https:\/\/doi.org\/10.1371\/journal.pone.0210234\n                  \n                .","journal-title":"PLoS One"},{"key":"9494_CR27","doi-asserted-by":"crossref","unstructured":"Nakayama, Kentaro, Naomi Nakayama, Ben Davidson, Jim J-C Sheu, Natini Jinawath, Antonio Santillan, Ritu Salani, et al. 2006. \u201cA BTB\/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival.\u201d \n                  www.ncbi.nlm.nih.gov\/entrez\/guery.fcgi?db-unigene\n                  \n                .","DOI":"10.1073\/pnas.0604083103"},{"issue":"11","key":"9494_CR28","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nmeth.3144","volume":"11","author":"AI Nesvizhskii","year":"2014","unstructured":"Nesvizhskii AI. Proteogenomics: concepts, applications and computational strategies. Nat Methods. 2014;11(11):1114\u201325. \n                  https:\/\/doi.org\/10.1038\/nmeth.3144\n                  \n                .","journal-title":"Nat Methods"},{"issue":"2","key":"9494_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/J.JMB.2010.12.041","volume":"407","author":"CD Nguyen","year":"2011","unstructured":"Nguyen CD, Mansfield RE, Leung W, Vaz PM, Loughlin FE, Grant RP, et al. Characterization of a family of RanBP2-type zinc fingers that can recognize single-stranded RNA. J Mol Biol. 2011;407(2):273\u201383. \n                  https:\/\/doi.org\/10.1016\/J.JMB.2010.12.041\n                  \n                .","journal-title":"J Mol Biol"},{"issue":"12","key":"9494_CR30","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/acs.jproteome.7b00375","volume":"16","author":"GS Omenn","year":"2017","unstructured":"Omenn GS, Lane L, Lundberg EK, Overall CM, Deutsch EW. Progress on the HUPO draft human proteome: 2017 metrics of the human proteome project. J Proteome Res. 2017;16(12):4281\u20137. \n                  https:\/\/doi.org\/10.1021\/acs.jproteome.7b00375\n                  \n                .","journal-title":"J Proteome Res"},{"key":"9494_CR31","doi-asserted-by":"publisher","unstructured":"Omenn GS, Lane L, Overall CM, Corrales FJ, Schwenk JM, Paik Y-K, et al. Progress on identifying and characterizing the human proteome: 2018 metrics from the HUPO human proteome project. J Proteome Res. 2018;17(12):4031\u201341. \n                  https:\/\/doi.org\/10.1021\/acs.jproteome.8b00441\n                  \n                .","DOI":"10.1021\/acs.jproteome.8b00441"},{"issue":"12","key":"9494_CR32","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1021\/acs.jproteome.8b00885","volume":"17","author":"Y-K Paik","year":"2018","unstructured":"Paik Y-K, Overall CM, Corrales F, Deutsch EW, Lane L, Omenn GS. Toward completion of the human proteome parts list: progress uncovering proteins that are missing or have unknown function and developing analytical methods. J Proteome Res. 2018;17(12):4023\u201330. \n                  https:\/\/doi.org\/10.1021\/acs.jproteome.8b00885\n                  \n                .","journal-title":"J Proteome Res"},{"key":"9494_CR33","doi-asserted-by":"publisher","unstructured":"Pascale F, Dummer R, Paolo A Ascierto, Helen J Gogas, Ana Arance, Mario Mandala, Gabriella Liszkay, et al. Encorafenib plus Binimetinib versus Vemurafenib or Encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial. Articles Lancet Oncol. 2018;19:603\u201318. \n                  https:\/\/doi.org\/10.1016\/S1470-2045(18)30142-6\n                  \n                .","DOI":"10.1016\/S1470-2045(18)30142-6"},{"issue":"8","key":"9494_CR34","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/labinvest.2013.84","volume":"93","author":"JM Pimiento","year":"2013","unstructured":"Pimiento JM, Larkin EM, Smalley KSM, Wiersma GL, Monks NR, Fedorenko IV, et al. Melanoma genotypes and phenotypes get personal. Lab Investig. 2013;93(8):858\u201367. \n                  https:\/\/doi.org\/10.1038\/labinvest.2013.84\n                  \n                .","journal-title":"Lab Investig"},{"key":"9494_CR35","doi-asserted-by":"publisher","unstructured":"Pita-Ju\u00e1rez Y, Altschuler G, Kariotis S, Wei W, Koler K, Green C, et al. The pathway coexpression network: revealing pathway relationships. PLoS Comput Biol. 2018;14(3). \n                  https:\/\/doi.org\/10.1371\/journal.pcbi.1006042\n                  \n                .","DOI":"10.1371\/journal.pcbi.1006042"},{"key":"9494_CR36","doi-asserted-by":"publisher","unstructured":"Swanton, Charles. 2018. \u201cCancer therapeutics through an evolutionary lens.\u201d J R Soc Med 111 (1): 8\u201314. \n                  https:\/\/doi.org\/10.1177\/0141076817742096\n                  \n                .","DOI":"10.1177\/0141076817742096"},{"issue":"1","key":"9494_CR37","doi-asserted-by":"publisher","first-page":"14677","DOI":"10.1038\/ncomms14677","volume":"8","author":"PM-K Tang","year":"2017","unstructured":"Tang PM-K, Zhou S, Meng X-M, Wang Q-M, Li C-J, Lian G-Y, et al. Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development. Nat Commun. 2017;8(1):14677. \n                  https:\/\/doi.org\/10.1038\/ncomms14677\n                  \n                .","journal-title":"Nat Commun"},{"issue":"1","key":"9494_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/pro.3307","volume":"27","author":"PJ Thul","year":"2018","unstructured":"Thul PJ, Lindskog C. The human protein atlas: a spatial map of the human proteome. Protein Science : A Publication of the Protein Society. 2018;27(1):233\u201344. \n                  https:\/\/doi.org\/10.1002\/pro.3307\n                  \n                .","journal-title":"Protein Science : A Publication of the Protein Society"},{"issue":"1","key":"9494_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10555-016-9613-5","volume":"35","author":"J T\u00edm\u00e1r","year":"2016","unstructured":"T\u00edm\u00e1r J, Vizkeleti L, Doma V, Barbai T, R\u00e1s\u00f3 E. Genetic progression of malignant melanoma. Cancer Metastasis Rev. 2016;35(1):93\u2013107. \n                  https:\/\/doi.org\/10.1007\/s10555-016-9613-5\n                  \n                .","journal-title":"Cancer Metastasis Rev"},{"key":"9494_CR40","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41576-019-0114-6","volume":"20","author":"S Turajlic","year":"2019","unstructured":"Turajlic S, Sottoriva A, Graham T, Swanton C. Resolving genetic heterogeneity in cancer. Nat Rev Genet. 2019;20:404\u201316. \n                  https:\/\/doi.org\/10.1038\/s41576-019-0114-6\n                  \n                .","journal-title":"Nat Rev Genet"},{"issue":"4","key":"9494_CR41","doi-asserted-by":"publisher","first-page":"862","DOI":"10.15252\/msb.20155865","volume":"12","author":"M Uhl\u00e9n","year":"2016","unstructured":"Uhl\u00e9n M, Hallstr\u00f6m BM, Lindskog C, Mardinoglu A, Pont\u00e9n F, Nielsen J. Transcriptomics resources of human tissues and organs. Mol Syst Biol. 2016;12(4):862. \n                  https:\/\/doi.org\/10.15252\/msb.20155865\n                  \n                .","journal-title":"Mol Syst Biol"},{"issue":"11","key":"9494_CR42","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1021\/acs.jproteome.6b00390","volume":"15","author":"W Wei","year":"2016","unstructured":"Wei W, Luo W, Wu F, Peng X, Zhang Y, Zhang M, et al. Deep coverage proteomics identifies more low-abundance missing proteins in human testis tissue with Q-exactive HF mass spectrometer. J Proteome Res. 2016;15(11):3988\u201397. \n                  https:\/\/doi.org\/10.1021\/acs.jproteome.6b00390\n                  \n                .","journal-title":"J Proteome Res"},{"key":"9494_CR43","doi-asserted-by":"publisher","unstructured":"Welinder, Charlotte, G\u00f6ran B. J\u00f6nsson, Christian Ingvar, Lotta Lundgren, Bo Baldetorp, H\u00e5kan Olsson, Thomas Breslin, Melinda Rezeli, Bo Jansson, Thomas E. Fehniger, et al. 2014a. \u201cAnalysis of alpha-synuclein in malignant melanoma \u2013 development of a SRM quantification assay.\u201d Edited by Benjamin Edward Rich. PLoS One 9 (10): e110804. \n                  https:\/\/doi.org\/10.1371\/journal.pone.0110804\n                  \n                .","DOI":"10.1371\/journal.pone.0110804"},{"issue":"3","key":"9494_CR44","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1021\/pr400876p","volume":"13","author":"C Welinder","year":"2014","unstructured":"Welinder C, J\u00f6nsson G, Ingvar C, Lundgren L, Baldetorp B, Olsson H, et al. Feasibility study on measuring selected proteins in malignant melanoma tissue by SRM quantification. J Proteome Res. 2014b;13(3):1315\u201326. \n                  https:\/\/doi.org\/10.1021\/pr400876p\n                  \n                .","journal-title":"J Proteome Res"},{"issue":"1","key":"9494_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2001-1326-2-7","volume":"2","author":"C Welinder","year":"2013","unstructured":"Welinder C, J\u00f6nsson G, Ingvar C, Lundgren L, Olsson H, Breslin T, et al. Establishing a Southern Swedish malignant melanoma OMICS and biobank clinical capability. Clin Transl Med. 2013;2(1):7. \n                  https:\/\/doi.org\/10.1186\/2001-1326-2-7\n                  \n                .","journal-title":"Clin Transl Med"},{"key":"9494_CR46","doi-asserted-by":"publisher","unstructured":"Welinder, Charlotte, Krzysztof Paw\u0142owski, Yutaka Sugihara, Maria Yakovleva, G\u00f6ran J\u00f6nsson, Christian Ingvar, Lotta Lundgren, et al. 2015. \u201cA protein deep sequencing evaluation of metastatic melanoma tissues.\u201d Edited by Yiqun G. Shellman. PLoS One 10 (4): e0123661. \n                  https:\/\/doi.org\/10.1371\/journal.pone.0123661\n                  \n                .","DOI":"10.1371\/journal.pone.0123661"},{"issue":"4","key":"9494_CR47","doi-asserted-by":"publisher","first-page":"e0176167","DOI":"10.1371\/journal.pone.0176167","volume":"12","author":"C Welinder","year":"2017","unstructured":"Welinder C, Paw\u0142owski K, Szasz AM, Yakovleva M, Sugihara Y, Malm J, et al. \u201cCorrelation of histopathologic characteristics to protein expression and function in malignant melanoma.\u201d Edited by Michal Zmijewski. PLoS One. 2017;12(4):e0176167. \n                  https:\/\/doi.org\/10.1371\/journal.pone.0176167\n                  \n                .","journal-title":"PLoS One"},{"issue":"15","key":"9494_CR48","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.jmb.2017.12.007","volume":"430","author":"L Zimmermann","year":"2018","unstructured":"Zimmermann L, Stephens A, Nam S-Z, Rau D, K\u00fcbler J, Lozajic M, et al. A completely reimplemented MPI bioinformatics toolkit with a new HHpred server at its core. J Mol Biol. 2018;430(15):2237\u201343. \n                  https:\/\/doi.org\/10.1016\/j.jmb.2017.12.007\n                  \n                .","journal-title":"J Mol Biol"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-019-09494-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10565-019-09494-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-019-09494-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T19:12:20Z","timestamp":1602184340000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10565-019-09494-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["9494"],"URL":"https:\/\/doi.org\/10.1007\/s10565-019-09494-4","relation":{},"ISSN":["0742-2091","1573-6822"],"issn-type":[{"value":"0742-2091","type":"print"},{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"21 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Regional Ethical Committee at Lund University, Southern Sweden, approval numbers: DNR 191\/2007, 101\/2013 and 2015\/266, 2015\/618. All patients involved in the study provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}